15th Jul 2022
The decisions to refuse these applications were appealed last year, and earlier this week the Board of Appeal at the EPO issued its written decision for the appeal on the first of these applications, J 08/20, which can be found here.
12th Jul 2022
We are pleased to introduce our new newsletter, Sustainable Future: Exploring innovations for the Energy Transition and Circular Economy.
4th Jul 2022
The UK Intellectual Property Office (UKIPO) has just (28 June 2022) published the results of a consultation with stakeholders on how Artificial Intelligence (AI) should be dealt with in the patent and copyright systems. This is the second UKIPO consultation on AI and IP in recent years. It focusses on issues surrounding inventorship, ownership and authorship for AI inventions and creations, and specifically whether or how IP law might need to change to adapt to the challenges posed by AI.
22nd Jun 2022
Since the regime was phased in from 1 April 2013, the UK Patent Box has enabled companies to apply a lower rate of Corporation Tax to worldwide profits earned from qualifying patented inventions and equivalent forms of intellectual property. The relief is given via a deduction from total taxable trading profits for a chargeable accounting period.
Biotechnology & Pharmaceuticals, Chemistry & Materials, Consumer Products & Manufacturing, Designs, Electronic & Electrical Devices, Featured News, IP news, Medical Devices & Digital Healthcare, Munich, Nederlands, R&G news, Technical Insights
10th Jun 2022
We are pleased to introduce our new newsletter, Digital Health: IP at the interface of healthcare and digital technology.
19th May 2022
Two recent decisions of the European Patent Office’s Boards of Appeal illustrate a risk faced by patent applications for artificial intelligence inventions: if the application does not describe the AI in enough detail then it can be refused for insufficient disclosure and lack of inventive step.
17th May 2022
The proposed European unitary patent system could come into force as early as this year, so it is important for patent owners to begin considering how they will make use of the new system, if at all. This article will explore some of the factors that organisations in the pharmaceutical sector should be considering in advance of the new system coming into effect.
11th May 2022
The European Patent Office (EPO) Guidelines relating to the patentability of Computer Implemented Inventions (CIIs) have been significantly amended following the publication of the seminal Enlarged Board of Appeal decision G1/19 on the patentability of computer simulations, reported here in 2021. The update places the T641/00 “COMVIK” approach at the centre of the test for patentability of CIIs, and includes a new discussion of its application to Artificial Intelligence inventions.